Gene-expression patterns predict phenotypes of immune-mediated thrombosis.

Area of Science:

• Genomics
• Immunology
• Hematology

Background:

• Antiphospholipid antibody syndrome (APS) is an autoimmune disorder characterized by thrombosis.
• Elevated antiphospholipid antibodies (aPLA) increase the risk of thrombotic events, necessitating lifelong anticoagulation.
• Current diagnostic and risk stratification methods for APS and aPLA-related thrombosis require refinement.

Purpose of the Study:

• To identify distinct gene expression profiles associated with APS.
• To predict the risk of thrombotic events in patients with aPLA.
• To explore a genomic approach for improved clinical management of thrombotic disorders.

Main Methods:

• DNA microarray analysis of peripheral blood RNA from 129 patients (APS with VTE, VTE without aPLA, aPLA only, healthy controls).
• Hierarchical clustering and binary regression methods were employed to analyze gene expression patterns.
• Validation of identified gene-expression profiles in independent patient cohorts.

Main Results:

• Gene-expression profiles successfully differentiated APS patients from those with VTE but without aPLA.
• Specific expression profiles accurately predicted patients with aPLA who were at high risk for thrombotic events.
• Validated profiles demonstrate the potential for genomic prediction of thrombosis risk.

Conclusions:

• Gene-expression profiling offers a novel genomic approach for identifying APS and predicting thrombotic risk in aPLA-positive individuals.
• This predictive capability can lead to more effective clinical management strategies for venous thromboembolism.
• The identified profiles may reflect underlying biological mechanisms contributing to APS and thrombosis.